ARCHIVES

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Cancer Control Budget Still $4 Million Short

January 28, 1977

In Brief: AMA Opposes Bill To Permit Heroin Use For Pain Control, Says Morphine Is Equally As Effective

March 23, 1984

LeMaistre To Retire As M.D. Anderson President In 1996

August 18, 1995

In Brief: Congress Finished Spending Bill, Reagan Signs It; NCI Gets $1.402 Billion, a $174.5 Million Raise

October 24, 1986

DCPC Advisors Consider Asking DRG For Section On Prevention & Control

May 14, 1993

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

March 24, 2006